STRATA Skin Sciences, Inc. to Report 3rd Quarter 2017 Financial Results on Thursday, November 9

-- Conference Call to Follow at 4:30 p.m. EST --

HORSHAM, Pa., Oct. 26, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatological conditions, will release third quarter financial results on Thursday, November 9, after the market close.  STRATA Skin Sciences President and Chief Executive Officer, Frank J. McCaney, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.

About STRATA Skin Sciences, Inc. (www.strataskinsciences.com) 
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC^® laser and VTRAC^® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystem, marketed specifically for the intended use of micropigmentation; and Nordlys, a multi-technology aesthetic laser device.

Investor Contacts:
Christina L. Allgeier                                                      
STRATA Skin Sciences, Inc.                                            
215 619 3267                                                                 
[email protected]                                                    

Bob Yedid
LifeSci Advisors, LLC
646-597-6989
[email protected]